The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index; 1 of the 50 sources its claims cite were checked for support.
Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
Open accessAbstract
BACKGROUND: Despite its success with compliant or supervised patients, disulfiram has been a controversial medication in the treatment of alcoholism. Often, study designs did not recognize a pivotal factor in disulfiram research, the importance of an open-label design. Our objectives are: (1) to analyze the efficacy and safety of disulfiram in RCTs in supporting abstinence and (2) to compare blind versus open-label studies, hypothesizing that blinded studies would show no difference between disulfiram and control groups because the threat would be evenly spread across all groups. METHODS AND FINDINGS: We searched PubMed, EMBASE and the Cochrane Central Register for RCTs on disulfiram use with alcoholics in comparison to any alcoholic control group. The primary outcome was defined by the authors of each trial. Additional analyses included: blind vs. open-label, with or without supervision, cocaine study or not, and type of control. Overall, the 22 included studies showed a higher success rate of disulfiram compared to controls Hedges'g = .58 (95%CI = .35-.82). When comparing blind and open-label RCTs, only open-label trials showed a significant superiority over controls g = .70 (95%CI = .46-.93). RCTs with blind designs showed no efficacy of disulfiram compared to controls. Disulfiram was also more effective than the control condition when compared to naltrexone g = .77, 95%CI = .52-1.02, to acamprosate g = .76, 95%CI = .04-1.48, and to the no disulfiram groups g = .43, 95%CI = .17-.69. LIMITS INCLUDE: (1) a population of 89% male subjects and (2) a high but unavoidable heterogeneity of the studies with a substantial I-square in most subgroups of studies. CONCLUSIONS: Blinded studies were incapable of distinguishing a difference between treatment groups and thus are incompatible with disulfiram research. Based on results with open-label studies, disulfiram is a safe and efficacious treatment compared to other abstinence supportive pharmacological treatments or to no disulfiram in supervised studies for problems of alcohol abuse or dependence.
Overview
CoChat Summary
TL;DR
This meta-analysis found that disulfiram was superior to controls in open-label randomized trials, but not in blinded trials, suggesting that blinding masks the key expectancy mechanism of the drug. It also found more adverse events with disulfiram, but no difference from controls in deaths or serious adverse events requiring hospitalization.
Key findings
- Across 22 RCTs and 2,414 subjects, disulfiram had a higher success rate than controls: Hedges’ g = 0.58 (95% CI 0.35–0.82); heterogeneity was I² = 72%. After trim-and-fill correction, the effect remained significant: g = 0.47 (95% CI 0.24–0.71).
- In the blind/open-label subgroup analysis, open-label trials showed benefit: g = 0.70 (95% CI 0.46–0.93), while blinded trials showed no efficacy: g = 0.01 (95% CI −0.29–0.32).
- With supervision, disulfiram was significantly superior to controls: g = 0.82 (95% CI 0.59–1.05; I² = 46%); without supervision it was not significant: g = 0.26 (95% CI −0.02–0.53).
- Compared with specific controls, disulfiram was superior to naltrexone (g = 0.77), acamprosate (g = 0.76), and no disulfiram (g = 0.43). It also showed a higher adverse-events rate ratio of 1.40 (95% CI 1.01–1.94).
Methods
- Systematic review and meta-analysis of randomized controlled trials comparing oral disulfiram with any control group in alcohol-dependent/abusing patients; databases searched were PubMed, EMBASE, Cochrane Central Register, plus manual search (last searches June–November 2012).
- Final sample included 22 studies published from 1973 to 2010; total analyzed sample was 2,414 subjects, with some studies involving comorbid cocaine dependence.
- Main analysis used Hedges’ g under a random-effects model, with subgroup analyses by blinding, supervision, cocaine vs non-cocaine studies, and control condition, plus funnel plots, trim-and-fill, leave-one-out sensitivity analyses, and meta-regression.
Limitations
- The paper states that the included studies had a high and unavoidable heterogeneity with substantial I² in most subgroups, and that there was a possible publication bias suggested by funnel-plot asymmetry in the overall and open-label analyses.
- The paper states a sample composition limitation: 89% male subjects, so generalizability to women is limited.
- Evident from the text: many studies were methodologically weak by Cochrane criteria—among the 22 studies, 6 met none of the six risk-of-bias criteria, and only 2 met four—and many outcomes were based on differing primary endpoints across trials.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
1 Valid · 0 Not valid · 21 Not checked · 74 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Compliance has been a serious impediment in disulfiram research in numerous studies [26], [27].”
§ Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis > Introduction
What the sources say
- Supportedcites [26] HM Pettinati, 2008, A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence, Addict Behav source
The Discussion states that taking fewer pills than prescribed 'has also been consistently reported in alcohol dependent populations for both disulfiram (Fuller, Rieckmann, McCarty, Smith et al., 2005)' and that 'typically disulfiram has had much higher nonadherence problems than naltrexone (De Witte et al., 2005; Fuller & Gordis, 2004; Suh et al., 2006)', i.e. a recurring problem credited to numerous studies. Results §3.2 adds that only 35.1% of patients received 80% or more of the possible disulfiram pills and that the modest adherence/exposure prevented meaningful post-hoc analyses of outcome, so compliance was indeed an impediment in this disulfiram trial. Together these support the paraphrase that compliance has been a serious impediment in disulfiram research. (LLM, conf=0.85)
- Not checked yetcites [27] RK Fuller, 1986, Disulfiram treatment of alcoholism. A Veterans Administration cooperative study, JAMA source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Disulfiram was also more effective than the control condition when compared to naltrexone g = .77, 95%CI = .52–1.02, to acamprosate g = .76, 95%CI = .04–1.48, and to the no disulfiram groups g = .43, 95%CI = .17–.69.”
§ Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis > Abstract > Methods and Findings
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Disulfiram was also more effective than the control condition when compared to naltrexone g = .77, 95%CI = .52–1.02, to acamprosate g = .76, 95%CI = .04–1.48, and to the no disulfiram groups g = .43, 95%CI = .17–.69.”
§ Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis > Abstract > Methods and Findings
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A visual inspection of the funnel plot revealed asymmetry, indicating a possible publication bias.”
§ Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis > Results > Disulfiram efficacy
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“I2 was 72%.”
§ Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis > Results > Disulfiram efficacy
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
51 more claims
Create a free account to see all 96 claims and to verify the 49 references still open.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 24
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a meta-analysis of 22 studies, disulfiram demonstrated a higher success rate in promoting abstinence compared to placebo in open-label trials [52].”
From A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder (2024) · cites this paper as [52]
Experimental — accuracy not yet measured
Citations
Cites
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962 · cited 1×
“Numerous studies have shown that the majority of patients who abuse cocaine also abuse alcohol, ranging from 50% to 90% [53,54,55,56,57,58].”
BackgroundAssessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396
Regier, D. A., Farmer, M. E., Rae, D. S., et al. (1990) · PubMed · Cited by 1,913
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.256.11.1449 · Cited by 541
Disulfiram Treatment of Alcoholism: A Veterans Administration Cooperative Study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.1986.03380110055026 · Cited by 431 · cited 10×
“In the larger study (n = 605) [27], only 20% of the 577 who completed the study were compliant.”
BackgroundInfluentialThe Development of a Questionnaire to Measure Severity of Alcohol Dependence *
Stockwell, T., Hodgson, R., Edwards, G., Taylor, C., & Rankin, H. (1979) · British Journal of Addiction to Alcohol & Other Drugs · doi:10.1111/j.1360-0443.1979.tb02415.x · Cited by 419
Carroll, K. M., Fenton, L. R., Ball, S. A., Nich, C., Frankforter, T. L., Shi, J., & Rounsaville, B. J. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.264 · Cited by 414 · cited 2×
“We were unable to obtain the baseline alcohol consumption for the sub sample of codependent patients in the Carroll et al study (2004) [43].”
MethodAlcoholism treatment by disulfiram and community reinforcement therapy
Azrin, N. H., Sisson, R. W., Meyers, R., & Godley, M. (1982) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(82)90050-7 · Cited by 411 · cited 2×
“Disulfiram has been used in the treatment of alcohol dependence with consistently successful results in individuals with high compliance or when medication intake has been directly supervised [1,2,3].”
Background
Research works printed but not linked: 2
- A De Sousa, 2009, An open label trial of naltrexone versus disulfiram in elderly patients with alcohol dependence, JPPS, 6, 85
- K Carroll, 2004, Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients, Archives of General Psychiatry, 61, 264, 10.1001/archpsyc.61.3.264 · DOI · Paper page
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Advances in the science and treatment of alcohol use disorder
Witkiewitz, K., Litten, R. Z., & Leggio, L. (2019) · Science Advances · doi:10.1126/sciadv.aax4043 · Cited by 592
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review
Kranzler, H. R., & Soyka, M. (2018) · JAMA · doi:10.1001/jama.2018.11406 · Cited by 580
Connor, J. P., Haber, P. S., & Hall, W. D. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00122-1 · Cited by 389
Hazardous drinking and alcohol use disorders
MacKillop, J., Agabio, R., Feldstein Ewing, S. W., Heilig, M., Kelly, J. F., Leggio, L., Lingford-Hughes, A., Palmer, A. A., Parry, C. D., Ray, L., et al. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00406-1 · Cited by 215
“Notably, evidence of the effectiveness of disulfiram has been strongest in trials using witnessed or otherwise supervised administration (such as in collaboration with a spouse or partner), with limited benefits in unwitnessed administration 274,275 , due to low medication compliance.”
Metadata
- Authors
- Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H.-J.
- Affiliations
- Inserm (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Paris-Sud (FR)
- Corresponding author
- Skinner, Marilyn D.
- ORCID
- Aubin, Henri-Jean
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-02-10
- Volume
- 9
- Issue
- 2
- Pages
- e87366
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3919718
- OpenAlex
- W2135168571
- Cited by
- 347
- References
- 71
- Citations by year
- 2026: 24 · 2025: 21 · 2024: 43 · 2023: 51 · 2022: 28 · 2021: 31 · 2020: 26 · 2019: 37 · 2018: 23 · 2017: 18 · 2016: 23 · 2015: 20 · 2014: 2
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
- Keywords
- disulfiram, alcoholism, alcoholism treatment, abstinence, naltrexone, acamprosate, supervised treatment, cocaine use, treatment efficacy, drug safety
- MeSH terms
- Adolescent, Adult, Aged, Alcohol Deterrents, Alcoholism, Cocaine, Disulfiram, Female, Humans, Male, Middle Aged, Case-Control Studies, Randomized Controlled Trials as Topic, Treatment Outcome, Endpoint Determination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis. https://app.cochat.ai/papers/10.1371/journal.pone.0087366
- The paper
- Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H.-J. (2014). Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis. PLoS ONE. https://doi.org/10.1371/journal.pone.0087366
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.